TRUOZA
DEAD

Serial Number

90815184

Owner

Teva Pharmaceuticals USA, Inc.

Attorney

Laurence Rickles

Filing Date

Jul 7, 2021

Add to watchlist:

No watchlists yet
View on USPTO

TRUOZA Trademark

Serial Number: 90815184

TRUOZA is a trademark filed by Teva Pharmaceuticals USA, Inc. on July 7, 2021. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Teva Pharmaceuticals USA, Inc. (587 trademarks)

650 Cathill Road
Sellersville, PA 18960

Entity Type: 03

Trademark Details

Filing Date

July 7, 2021

Registration Date

Not Registered

Published for Opposition

December 21, 2021

Goods & Services

Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease; Pharmaceutical preparations for the prevention and treatment of depression; Pharmaceutical preparations for the prevention and treatment of psychological disorders; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of cardiovascular and blood pressure disorders; Pharmaceutical preparations for the prevention and treatment of irritable bowel syndrome; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of osteoporosis; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of sexual dysfunction; Pharmaceutical preparations for the prevention and treatment of symptoms associated with uterine fibroids; Pharmaceutical preparations for the prevention and treatment of urinary incontinence and overactive bladder; Pharmaceutical preparations that support, encourage and promote bone strength; Pharmaceutical preparations that support, encourage and promote bone health; Pharmaceutical preparations used in the treatment of bone disorders and bone diseases; Pharmaceutical preparations, namely, injectable contraceptives; Pharmaceutical preparations, namely, contraceptive preparations; Pharmaceutical preparations, namely, fertility enhancement preparations; Pharmaceutical preparations, namely, hormone replacement therapy preparations; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical agents affecting the central nervous system; Pharmaceutical agents affecting circulatory systems; Pharmaceutical agents affecting sensory organs; Pharmaceutical agents affecting urogenital organs; Pharmaceutical agents affecting peripheral nervous system

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Oct 9, 2025 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Oct 9, 2025 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 14, 2024 EXRA
SOU EXTENSION 5 GRANTED
Aug 14, 2024 EX5G
SOU EXTENSION 5 FILED
Aug 14, 2024 EXT5
SOU TEAS EXTENSION RECEIVED
Aug 14, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 2, 2024 EXRA
SOU EXTENSION 4 GRANTED
May 1, 2024 EX4G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Apr 30, 2024 AITU
SOU EXTENSION RECEIVED WITH TEAS PETITION
Mar 19, 2024 TPEX
NOTICE OF REVIVAL - E-MAILED
Mar 19, 2024 NREV
PETITION TO REVIVE-GRANTED
Mar 19, 2024 PETG
TEAS PETITION TO REVIVE RECEIVED
Mar 19, 2024 PROA
TEAS PETITION TO REVIVE RECEIVED
Mar 19, 2024 PROA
ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Mar 18, 2024 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Mar 18, 2024 ABN6
SOU EXTENSION 4 FILED
Feb 15, 2024 EXT4
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 4, 2023 EXRA
SOU EXTENSION 3 GRANTED
Aug 2, 2023 EX3G
SOU EXTENSION 3 FILED
Aug 2, 2023 EXT3
SOU TEAS EXTENSION RECEIVED
Aug 2, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 8, 2023 EXRA
SOU EXTENSION 2 GRANTED
Feb 6, 2023 EX2G
SOU EXTENSION 2 FILED
Feb 6, 2023 EXT2
SOU TEAS EXTENSION RECEIVED
Feb 6, 2023 EEXT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 2, 2023 TCCA
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Feb 2, 2023 EWAF
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 2, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 2, 2023 REAP
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 28, 2022 EXRA
SOU EXTENSION 1 GRANTED
Jul 26, 2022 EX1G
SOU EXTENSION 1 FILED
Jul 26, 2022 EXT1
SOU TEAS EXTENSION RECEIVED
Jul 26, 2022 EEXT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 7, 2022 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 7, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 7, 2022 REAP
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Feb 15, 2022 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 21, 2021 NPUB
PUBLISHED FOR OPPOSITION
Dec 21, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 1, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 12, 2021 CNSA
ASSIGNED TO EXAMINER
Nov 12, 2021 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 15, 2021 NWOS
NEW APPLICATION ENTERED
Jul 10, 2021 NWAP